Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy

BACKGROUND: Chronic rejection characterized by chronic allograft vasculopathy (CAV) remains a major obstacle to long-term graft survival. Due to multiple complicated mechanisms involved, a novel therapy for CAV remains exploration. Although mesenchymal stromal cells (MSCs) have been ubiquitously app...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ya-fei, Kong, De-jun, Qin, Hong, Zhu, Yang-lin, Li, Guang-ming, Sun, Cheng-lu, Zhao, Yi-ming, Wang, Hong-da, Hao, Jing-peng, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116651/
https://www.ncbi.nlm.nih.gov/pubmed/33995416
http://dx.doi.org/10.3389/fimmu.2021.672849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116651/
https://www.ncbi.nlm.nih.gov/pubmed/33995416
http://dx.doi.org/10.3389/fimmu.2021.672849

Ejemplares similares